TrialJapanese journal of clinical oncology2019

Efficacy and safety of sunitinib in Japanese patients with progressive, advanced/metastatic, well-differentiated, unresectable pancreatic neuroendocrine tumors: final analyses from a Phase II study.

Tetsuhide Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.